AC0010
Phase 1/2UNKNOWN 1 views this week 0 watching💤 Quiet
Interest: 28/100
28
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Non-Small Cell Lung Cancer
Conditions
Non-Small Cell Lung Cancer
Trial Timeline
Sep 1, 2014 → Dec 1, 2017
NCT ID
NCT02274337About AC0010
AC0010 is a phase 1/2 stage product being developed by Sun Pharmaceutical for Non-Small Cell Lung Cancer. The current trial status is unknown. This product is registered under clinical trial identifier NCT02274337. Target conditions include Non-Small Cell Lung Cancer.
What happened to similar drugs?
20 of 20 similar drugs in Non-Small Cell Lung Cancer were approved
Approved (20) Terminated (2) Active (0)
Hype Score Breakdown
Clinical
9
Activity
4
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02274337 | Phase 1/2 | UNKNOWN |
Competing Products
20 competing products in Non-Small Cell Lung Cancer